MSCs derived membrane coating nanoparticles targeted delivery itaconic acid to regulate M1 macrophage pyroptosis for osteoarthritis therapy
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Inflammasome and immune disorders · Curcumin's Biomedical Applications · Spondyloarthritis Studies and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (41)
Show source-provided references
1. The regulation of cartilage extracellular matrix homeostasis in joint cartilage degeneration and regeneration
2. Synovial inflammation in osteoarthritis progression10.1038/s41584-022-00749-9 ↗
3. Current strategies in multiphasic scaffold design for osteochondral tissue engineering: a review10.1002/jbm.a.35356 ↗
4. Role of the calcified cartilage layer of an integrated trilayered silk fibroin scaffold used to regenerate osteochondral defects in rabbit knees10.1021/acsbiomaterials.9b01661 ↗
5. Regional and sustained dual -release of growth factors from biomimetic tri-layered scaffolds for the repair of large-scale osteochondral defects
6. Cell-free decellularized cartilage extracellular matrix scaffolds combined with interleukin 4 promote osteochondral repair through immunomodulatory macrophages: in vitro and in vivo preclinical study10.1016/j.actbio.2021.03.054 ↗
7. Progressive waves of IL-1β release by primary human monocytes via sequential activation of vesicular and gasdermin D-mediated secretory pathways10.1038/s41419-018-1121-9 ↗
8. Synovial macrophages in cartilage destruction and regeneration—Lessons learnt from osteoarthritis and synovial chondromatosis10.1088/1748-605X/ac3d74 ↗
9. The NLRP3 inflammasome: molecular activation and regulation to therapeutics10.1038/s41577-019-0165-0 ↗
10. Mitophagy impairment mediates the pathogenesis of CoCrMo particle-induced osteolysis via NLRP3/caspase-1/GSDMD-dependent pyroptosis in macrophages10.1016/j.cej.2022.135115 ↗
11. The coming decade of cell death research: five riddles10.1016/j.cell.2019.04.024 ↗
12. Plasma-derived exosomes contribute to pancreatitis-associated lung injury by triggering NLRP3-dependent pyroptosis in alveolar macrophages10.1016/j.bbadis.2020.165685 ↗
13. Mechanosignalling in cartilage: an emerging target for the treatment of osteoarthritis10.1038/s41584-021-00724-w ↗
14. Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation10.1016/j.cmet.2016.06.004 ↗
15. The immunomodulatory potential of the metabolite itaconate10.1016/j.it.2019.05.007 ↗
16. Modification of proteins by metabolites in immunity10.1016/j.immuni.2020.09.014 ↗
17. Succination inactivates gasdermin D and blocks pyroptosis10.1126/science.abb9818 ↗
18. Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity10.1126/science.aan4665 ↗
19. Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf210.1073/pnas.1603907113 ↗
20. A multifunctional anti-inflammatory drug that can specifically target activated macrophages, massively deplete intracellular H2O2, and produce large amounts CO for a highly efficient treatment of osteoarthritis10.1016/j.biomaterials.2020.120155 ↗
21. Neutrophil membrane-coated nanoparticles inhibit synovial inflammation and alleviate joint damage in inflammatory arthritis10.1038/s41565-018-0254-4 ↗
22. Aligned microfiber-induced macrophage polarization to guide schwann-cell-enabled peripheral nerve regeneration10.1016/j.biomaterials.2021.120767 ↗
23. New insights into crosstalk between pyroptosis and autophagy co-induced by molybdenum and cadmium in duck renal tubular epithelial cells10.1016/j.jhazmat.2021.126138 ↗
24. Macrophages regulate the progression of osteoarthritis10.1016/j.joca.2020.01.007 ↗
25. Human osteoarthritic synovium impacts chondrogenic differentiation of mesenchymal stem cells via macrophage polarisation state10.1016/j.joca.2014.05.021 ↗
26. Osteoclast-associated receptor blockade prevents articular cartilage destruction via chondrocyte apoptosis regulation10.1038/s41467-020-18208-y ↗
27. Ageing and the pathogenesis of osteoarthritis10.1038/nrrheum.2016.65 ↗
28. Redox and NF-κB signaling in osteoarthritis10.1016/j.freeradbiomed.2018.09.025 ↗
29. Polyethylene wear particles play a role in development of osteoarthritis via detrimental effects on cartilage, meniscus, and synovium10.1016/j.joca.2013.09.013 ↗
30. Activated macrophage membrane-coated nanoparticles relieve osteoarthritis-induced synovitis and joint damage10.1016/j.biomaterials.2023.122036 ↗
31. One step synthesis of antimicrobial peptide protected silver nanoparticles: the core-shell mutual enhancement of antibacterial activity10.1016/j.colsurfb.2019.110704 ↗
32. Targeted silver nanoparticles for rheumatoid arthritis therapy via macrophage apoptosis and Re-polarization10.1016/j.biomaterials.2020.120390 ↗
33. Self-assembled hyaluronic acid nanoparticles for osteoarthritis treatment10.1016/j.biomaterials.2021.120967 ↗
34. Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation10.1016/j.cmet.2016.06.004 ↗
35. 4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to exert anti-inflammatory effects10.1038/s41467-019-13078-5 ↗
36. Nanomedicines reprogram synovial macrophages by scavenging nitric oxide and silencing CA9 in progressive osteoarthritis
37. Nrf2-mediated anti-inflammatory polarization of macrophages as therapeutic targets for osteoarthritis
38. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis10.1038/nrrheum.2010.196 ↗
39. Itaconate attenuates osteoarthritis by inhibiting STING/NF-κB axis in chondrocytes and promoting M2 polarization in macrophages10.1016/j.bcp.2022.114935 ↗
40. Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP110.1038/nature25986 ↗
41. The immune microenvironment in cartilage injury and repair10.1016/j.actbio.2021.12.006 ↗